Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 951 - 975 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Diacylglycerophosphoinositolglycans LMGP15010092
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/14:0)
126457460 1144.615833 C54H97O23P
Diacylglycerophosphoinositolglycans LMGP15010058
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:1(9Z))
126457426 1146.631483 C54H99O23P
Diacylglycerophosphoinositolglycans LMGP15010086
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/14:0)
126457454 1146.631483 C54H99O23P
Diacylglycerophosphoinositolglycans LMGP15010057
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:0)
126457425 1148.647133 C54H101O23P
Diacylglycerophosphoinositolglycans LMGP15010080
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/14:0)
126457448 1148.647133 C54H101O23P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA04
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • asialo-GM2(d18:1/22:0)
44260487 1148.791018 C60H112N2O18
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA04
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Lc3Cer(d18:1/22:0)
44260615 1148.791018 C60H112N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA04
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/22:0)
44261951 1148.791018 C60H112N2O18
Gangliosides LMSP0601AJ01
  • GM3(d18:1/16:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262036 84674 1152.713163 C57H104N2O21
LMSL03001275
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R-pentamethyl)-11-hydroxy-octacosanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/28:0(2Me[S],4Me[S],6Me[S],8Me[R],10Me[R],11OH))
126457716 1152.793327 C61H116O17S
LMSL03001286
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R-pentamethyl)-11-hydroxy-hexacosanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/26:0(2Me[S],4Me[S],6Me[S],8Me[R],10Me[R],11OH))
126457727 1152.793327 C61H116O17S
Diacylglycerophosphoinositolglycans LMGP15010077
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:2(9Z,12Z)/16:2(9Z,12Z))
126457445 1154.600183 C55H95O23P
Diacylglycerophosphoinositolglycans LMGP15010071
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/16:2(9Z,12Z))
126457439 1156.615833 C55H97O23P
Diacylglycerophosphoinositolglycans LMGP15010076
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:2(9Z,12Z)/16:1(9Z))
126457444 1156.615833 C55H97O23P
Diacylglycerophosphoinositolglycans LMGP15010065
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:2(9Z,12Z))
126457433 1158.631483 C55H99O23P
Diacylglycerophosphoinositolglycans LMGP15010070
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/16:1(9Z))
126457438 1158.631483 C55H99O23P
Diacylglycerophosphoinositolglycans LMGP15010075
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:2(9Z,12Z)/16:0)
126457443 1158.631483 C55H99O23P
Diacylglycerophosphoinositolglycans LMGP15010055
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/18:1(9Z))
126457423 1160.647133 C55H101O23P
Diacylglycerophosphoinositolglycans LMGP15010064
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:1(9Z))
126457432 1160.647133 C55H101O23P
Diacylglycerophosphoinositolglycans LMGP15010069
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/16:0)
126457437 1160.647133 C55H101O23P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA08
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Gb3(d18:1/26:1(17Z))
44260171 133816 1161.811419 C62H115NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ08
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Isoglobotriglycosylceramide(d18:1/26:1(17Z))
44261571 1161.811419 C62H115NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA08
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261947 1161.811419 C62H115NO18
Diacylglycerophosphoinositolglycans LMGP15010054
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/18:0)
126457422 1162.662783 C55H103O23P
Diacylglycerophosphoinositolglycans LMGP15010063
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:0)
126457431 1162.662783 C55H103O23P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024